Full List Of Stories
Wood Group returns to growth but debt cutting disappoints
Wood Group returned to growth in 2018 but said its growth cutting efforts would be slower than it planned after the merger with Amec Foster Wheeler.
Oxford BioDynamics biomarker to be used in prostate cancer test trial
Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest ‘EpiSwitch’ biomarker signature for the blood-based diagnosis of prostate cancer in the ‘PROSTAGRAM’ trial.
ITM Power sells electrolyser to Toyota Australia
Energy storage and clean fuel company ITM Power announced on Tuesday that Toyota Australia has purchased a 0. 25MW rapid-response PEM electrolyser from it.
InstraStrata awards engineering design contract to Costain
Natural gas storage company InfraStrata has awarded an engineering design works contract to Costain, it announced on Tuesday, to enable the £65m cost savings it identified during the front-end engineering and design (FEED) process to be realised on its Islandmagee gas storage project.
Kazera upbeat on progress in Namibia
Investment company Kazera Global announced on Tuesday that the borehole drilling campaign at both the Homestead and Purple Haze deposits had been completed.
Asia report: Markets mixed as investors look to Fed
Markets in Asia finished in a mixed state on Tuesday, as investors closed their wallets ahead of this month’s Federal Reserve meeting in the United States.
Bloomsbury Publishing ends year in line with expectations
Bloomsbury Publishing issued a pre-close trading update for the 12 months ended 28 February on Tuesday, saying it expected results for the year to be in line with the board's expectations.
Roche gets FDA approval for Tecentriq chemotherapy combination
Roche announced on Tuesday that the US Food and Drug Administration (FDA) has approved ‘Tecentriq’ (atezolizumab), in combination with carboplatin and etoposide chemotherapy, for the initial treatment of adults with extensive-stage small cell lung cancer.
Cambridge Cognition wins biggest digital health contract to date
Neuroscience technology company Cambridge Cognition Holdings announced a “significant” new contract on Tuesday, providing its digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.
Oncimmune acquires Protagen Diagnostics in £4.11m deal
Oncimmune Holdings has acquired Protagen Diagnostics for a total consideration of up to £4. 11m, it announced on Tuesday, to be paid by the allotment of up to 2,635,910 Oncimmune ordinary shares at 156p each 0 a premium of 71% to the closing mid-market price on 18 March.
HgCapital offloads investment in Foundry to Roper Technologies
HgCapital Trust announced the sale of high‑end visual effects and 3D design software developer Foundry to diversified technology company Roper Technologies on Tuesday, for £410m in cash.
Ferrexpo delays 2018 results amid Blooming Land review
Ferrexpo announced it was delaying the publication of its 2018 results on Tuesday, due to ongoing work on the independent review into its charitable donations to Blooming Land.
Essentra buys out Dubai joint venture partner in £11.6m deal
Essentra announced the acquisition of the 49% minority interest in its filters joint venture, Essentra MEA, from Aberdeen International, which is part of the BBM Bommidala group.
Antofagasta earnings fall as revenue remains stable
Antofagasta reported almost flat revenue for its full year on Tuesday, with the figure falling 0. 3% to $4. 73bn, reflecting a 6. 3% decrease in the realised copper price being almost completely offset by higher copper sales volumes and higher molybdenum revenue.
Ocado sales barely dented by fire, Antofagasta earnings down on flat revenue
London open The FTSE 100 was expected to open one point higher on Tuesday, having closed up 0. 98% at 7,299. 19 on Monday.
US close: Markets higher ahead of Fed meeting
Wall Street stocks kept their heads above water on Monday, despite the ongoing drag from Boeing, and as investors looked to the Federal Reserve policy announcement in the coming week.